The latest thoracic oncology news
Call for action on understudied lung cancer in never-smokers
Lung cancer patients who have never smoked make up a significant and growing share of…
Browsing: Lung Cancer
Call for action on understudied lung cancer in never-smokers
Lung cancer patients who have never smoked make up a significant and growing share of…
Chrono-oncology: Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
A randomised phase III trial published in Nature Medicine has reported an association between the…
Adjuvant aumolertinib significantly improves disease-free survival after resection of EGFR-mutant NSCLC
New data from the phase III ARTS trial published in The Lancet Oncology confirm that…
Epithelial–mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC)
Epithelial–mesenchymal transition (EMT) is a biological process that involves the transformation of epithelial cells into cells with…
Study identifies tumour progression pattern as predictor of survival after first-line NSCLC therapy
New Australian research published in Cancer Letters suggests that how advanced non-small cell lung cancer…
Which lung cancer subtypes are associated with different air pollutants?
A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by…
Inflammation fuels one of the most aggressive forms of cancer
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer,…
AI-driven study reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…